AlTi Global Inc. Has $13.04 Million Position in CME Group Inc. (NASDAQ:CME)

AlTi Global Inc. decreased its holdings in shares of CME Group Inc. (NASDAQ:CME) by 10.5% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 55,637 shares of the financial services provider’s stock after selling 6,532 shares during the period. AlTi Global Inc.’s holdings in CME Group were worth $13,043,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. SJS Investment Consulting Inc. lifted its position in CME Group by 570.6% in the 4th quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 97 shares in the last quarter. New Age Alpha Advisors LLC lifted its holdings in shares of CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 43 shares in the last quarter. Financial Life Planners purchased a new position in shares of CME Group during the fourth quarter valued at approximately $32,000. Knuff & Co LLC bought a new stake in CME Group during the fourth quarter worth $33,000. Finally, Fortitude Family Office LLC raised its position in CME Group by 120.3% in the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after buying an additional 83 shares during the last quarter. 87.75% of the stock is owned by institutional investors.

CME Group Stock Performance

NASDAQ CME opened at $280.45 on Friday. The firm has a market cap of $101.06 billion, a P/E ratio of 29.00, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The company’s 50 day moving average is $261.34 and its 200-day moving average is $243.61. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $282.10.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The business had revenue of $1.64 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter in the previous year, the firm posted $2.50 EPS. The business’s revenue for the quarter was up 10.4% compared to the same quarter last year. Sell-side analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th were given a dividend of $1.25 per share. The ex-dividend date was Friday, March 7th. This is a boost from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a dividend yield of 1.78%. CME Group’s dividend payout ratio is currently 50.30%.

Insider Transactions at CME Group

In related news, Director Dennis Suskind sold 1,000 shares of CME Group stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $271.28, for a total transaction of $271,280.00. Following the completion of the sale, the director now owns 2,915 shares of the company’s stock, valued at approximately $790,781.20. This trade represents a 25.54 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Suzanne Sprague sold 1,500 shares of the company’s stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $256.83, for a total value of $385,245.00. Following the completion of the transaction, the chief operating officer now owns 8,036 shares in the company, valued at $2,063,885.88. This represents a 15.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 30,076 shares of company stock valued at $7,670,976. 0.30% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several research firms have recently issued reports on CME. Morgan Stanley upped their target price on shares of CME Group from $301.00 to $304.00 and gave the stock an “overweight” rating in a research note on Thursday, April 24th. JPMorgan Chase & Co. decreased their price objective on shares of CME Group from $223.00 to $211.00 and set an “underweight” rating for the company in a research note on Thursday, April 24th. Oppenheimer boosted their target price on CME Group from $269.00 to $279.00 and gave the stock an “outperform” rating in a research note on Friday, April 11th. Barclays increased their price target on CME Group from $279.00 to $283.00 and gave the company an “equal weight” rating in a research report on Wednesday, April 23rd. Finally, Keefe, Bruyette & Woods lifted their price target on CME Group from $265.00 to $273.00 and gave the stock a “market perform” rating in a report on Thursday, April 24th. Three equities research analysts have rated the stock with a sell rating, seven have given a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $256.80.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.